Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Traws Pharma, Inc. (TRAW) had Consolidated Net Income/Loss of $-3.05M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-2.61M |
|
-- |
|
-- |
|
$3.17M |
|
$-3.17M |
|
$0.12M |
|
$-3.05M |
|
$-3.05M |
|
$-3.05M |
|
$-3.05M |
|
|
Consolidated Net Income/Loss |
$-3.05M |
$-3.05M |
|
$-3.17M |
|
$-3.13M |
|
15.86M |
|
15.86M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$9.02M |
|
$0.01M |
|
$2.45M |
|
$11.47M |
|
$9.73M |
|
-- |
|
$0.04M |
|
$9.78M |
|
$1.69M |
|
$-0.75M |
|
$1.69M |
|
15.27M |
|
| Cash Flow Statement Financials | |
$-10.08M |
|
-- |
|
$11.29M |
|
$3.82M |
|
$5.02M |
|
$1.20M |
|
$1.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.93 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-180.60% |
|
407.20% |
|
-26.63% |
|
-180.60% |
|
$0.11 |
|
$-0.64 |
|
$-0.64 |
|